Nanoparticle vaccine shows potential as immunotherapy to fight multiple cancer types
Researchers from Southwestern Medical Center have developed a first-of-its-kind nanoparticle vaccine immunotherapy that targets several different cancer types. The nanovaccine consists of tumor antigens inside a synthetic polymer nanoparticle vaccines. April 24, 2017